Signifier Medical Technologies, a company with headquarters in London, UK, and Massachusetts, has created a new treatment for obstructive sleep apnea, and it is the first to be used during waking hours.
Unlike conventional sleep apnea devices, the eXciteOSA is designed to be used for short periods during the day and employs electrical stimulation to improve tongue muscle function, helping keep the airway open during sleep. It was recently authorized for sale by the FDA.
Sleep apnea involves airway obstruction during sleep and can have a variety of serious consequences, including cancer and cardiovascular disease. In many people the condition is undiagnosed, but for those who are aware of their condition, there are effective treatments available.
Conventional treatments typically involve continuous pressure applied to the airway through a face mask. While this works well, some users find that this disrupts their sleep, and it isn’t a good fit for everyone. This inspired the eXciteOSA device, which is applied to the tongue for 20 minutes each day for a total of six weeks, and then twice per week thereafter.
Our Vision
We aspire to revolutionize the sleep market with novel and ground-breaking products that will help solve the conditions of snoring and mild sleep apnoea, making a real impact on the lives of millions of people globally, in an area with a significant unmet medical need.
Driving Innovation in the Sleep Market
Signifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialization of innovative and non-invasive solutions for patients with snoring and sleep-disordered breathing conditions.
Signifier Medical Pioneers in challenging the wisdom of conventional snoring and sleep apnoea treatments, we’ve created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.
Also Read: MIRROR Home Exercise – The Future of Fitness Is Here
